These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9301565)

  • 41. Attention-deficit/hyperactivity disorder: evidence-based diagnosis and management for primary care clinicians.
    Liu YH; Stein MT
    Minerva Pediatr; 2004 Dec; 56(6):567-83. PubMed ID: 15765020
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hallucinations and other psychotic symptoms associated with the use of attention-deficit/hyperactivity disorder drugs in children.
    Mosholder AD; Gelperin K; Hammad TA; Phelan K; Johann-Liang R
    Pediatrics; 2009 Feb; 123(2):611-6. PubMed ID: 19171629
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Psychiatric comorbidity differences in clinic-referred children and adolescents with ADHD according to the subtypes and gender.
    Ghanizadeh A
    J Child Neurol; 2009 Jun; 24(6):679-84. PubMed ID: 19491114
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
    Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
    Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Low-dose atomoxetine for maintenance treatment of attention-deficit/hyperactivity disorder.
    Newcorn JH; Michelson D; Kratochvil CJ; Allen AJ; Ruff DD; Moore RJ;
    Pediatrics; 2006 Dec; 118(6):e1701-6. PubMed ID: 17101710
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The diagnosis and management of attention-deficit/hyperactivity disorder in preschool children: the state of our knowledge and practice.
    Dreyer BP
    Curr Probl Pediatr Adolesc Health Care; 2006 Jan; 36(1):6-30. PubMed ID: 16360075
    [No Abstract]   [Full Text] [Related]  

  • 47. Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.
    Brown RT; Amler RW; Freeman WS; Perrin JM; Stein MT; Feldman HM; Pierce K; Wolraich ML; ;
    Pediatrics; 2005 Jun; 115(6):e749-57. PubMed ID: 15930203
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Aggressive behavior in patients with attention-deficit/hyperactivity disorder, conduct disorder, and pervasive developmental disorders.
    Weller EB; Rowan A; Elia J; Weller RA
    J Clin Psychiatry; 1999; 60 Suppl 15():5-11. PubMed ID: 10418807
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Can dietary intervention play a part in the treatment of attention deficit and hyperactivity disorder?
    Marcason W
    J Am Diet Assoc; 2005 Jul; 105(7):1161-2. PubMed ID: 15983541
    [No Abstract]   [Full Text] [Related]  

  • 50. An n-of-1 trial service in clinical practice: testing the effectiveness of stimulants for attention-deficit/hyperactivity disorder.
    Nikles CJ; Mitchell GK; Del Mar CB; Clavarino A; McNairn N
    Pediatrics; 2006 Jun; 117(6):2040-6. PubMed ID: 16740846
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Global issues related to the impact of untreated attention-deficit/hyperactivity disorder from childhood to young adulthood.
    Barkley RA
    Postgrad Med; 2008 Sep; 120(3):48-59. PubMed ID: 18824825
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessment and treatment of disturbed sleep in attention deficit hyperactivity disorder.
    Hoban TF
    Expert Rev Neurother; 2004 Mar; 4(2):307-16. PubMed ID: 15853572
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Attention deficit hyperactivity disorder. Preface.
    Rohde LA; Faraone SV
    Child Adolesc Psychiatr Clin N Am; 2008 Apr; 17(2):xvii-xix. PubMed ID: 18295144
    [No Abstract]   [Full Text] [Related]  

  • 54. Geographic variation in receipt of psychotherapy in children receiving attention-deficit/hyperactivity disorder medications.
    Gellad WF; Stein BD; Ruder T; Henderson R; Frazee SG; Mehrotra A; Donohue JM
    JAMA Pediatr; 2014 Nov; 168(11):1074-6. PubMed ID: 25243391
    [No Abstract]   [Full Text] [Related]  

  • 55. Play school.
    Callaghan L
    Nurs Times; 1992 Dec 16-29; 88(51):44-6. PubMed ID: 1291981
    [No Abstract]   [Full Text] [Related]  

  • 56. [Hyperkinetic syndrome--a modern myth? MBD (minimal brain dysfunction)-syndrome].
    Fossen A; Wester K
    Tidsskr Nor Laegeforen; 1978 Mar; 98(7-8):379-83. PubMed ID: 635873
    [No Abstract]   [Full Text] [Related]  

  • 57. [What are the therapeutic possibilities which can be translated into reality by a public health paediatrician responsible for a child with minimal cerebral dysfunction and what are his duties? Legal possibilities (author's transl)].
    Rutz M
    Offentl Gesundheitswes; 1978 Jul; 40(7):463-5. PubMed ID: 150570
    [No Abstract]   [Full Text] [Related]  

  • 58. Complementary treatment options for childhood and adolescent attention deficit/hyperactivity disorder.
    Costelle D
    Ky Nurse; 2014; 62(1):5-6. PubMed ID: 24564010
    [No Abstract]   [Full Text] [Related]  

  • 59. Practice parameters for the assessment and treatment of attention-deficit hyperactivity disorder. American Academy of Child and Adolescent Psychiatry.
    J Am Acad Child Adolesc Psychiatry; 1991 May; 30(3):I-III. PubMed ID: 1369639
    [No Abstract]   [Full Text] [Related]  

  • 60. Child psychiatry. 3. The hyperactive child.
    Bruce D; McCuish A
    Nurs Times; 1981 Oct 14-20; 77(42):suppl 6-7. PubMed ID: 6913925
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.